AcelRx Pharmaceuticals Inc (ACRX.O) News| Reuters.com
Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

2.57USD
24 Jun 2016
Change (% chg)

$-0.16 (-5.86%)
Prev Close
$2.73
Open
$2.60
Day's High
$2.65
Day's Low
$2.56
Volume
4,021,180
Avg. Vol
336,868
52-wk High
$5.88
52-wk Low
$2.56

Select another date:

Tue, Jun 21 2016

BRIEF-Acelrx enters controlled equity offering sales agreement

* Entered controlled equity offering sales agreement to offer and sell shares of common stock par value $0.001 per share of up to $40 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

BRIEF-AcelRx Pharmaceuticals says presents results from Phase 3 study of ARX-04

* AcelRx pharmaceuticals inc says co presents results from phase 3 study of ARX-04 following ambulatory abdominal surgeries at Euroanaesthesia

BRIEF-AcelRx Pharmaceuticals reports Q1 loss per share $0.25

* AcelRx pharmaceuticals provides corporate update and reports first quarter 2016 financial results

BRIEF-Acelrx Pharmaceuticals names Howard Rosen as CEO

* Acelrx pharmaceuticals names howard b. Rosen as chief executive officer and provides update on clinical development activities and corporate priorities for 2016

Select another date: